Covid-19: EU Countries Spent Over €220m Stockpiling Remdesivir Despite Lack of Effectiveness, Finds Investigation

“The question for the European Commission is: why did it not have a contract with Gilead with an escape clause based on the Solidarity trial outcome?” Professor Brook Baker tells the British Medical Journal. “Regulators and authorities have an ongoing responsibility to ensure safety and efficacy.”